| Primary |
| Schizophrenia |
21.2% |
| Bipolar Disorder |
19.7% |
| Drug Use For Unknown Indication |
13.6% |
| Dystonia |
6.1% |
| Tremor |
6.1% |
| Psychotic Disorder |
4.5% |
| Attention Deficit/hyperactivity Disorder |
3.0% |
| Depression |
3.0% |
| Gastrointestinal Infection |
3.0% |
| Hypertension |
3.0% |
| Schizoaffective Disorder |
3.0% |
| Abnormal Behaviour |
1.5% |
| Akathisia |
1.5% |
| Asthma |
1.5% |
| Dementia Alzheimer's Type |
1.5% |
| Dyskinesia |
1.5% |
| Extrapyramidal Disorder |
1.5% |
| Hypothyroidism |
1.5% |
| Schizophrenia, Paranoid Type |
1.5% |
| Tardive Dyskinesia |
1.5% |
|
| Tremor |
17.6% |
| Tardive Dyskinesia |
11.8% |
| Wrong Drug Administered |
8.8% |
| Dizziness |
5.9% |
| Dyspepsia |
5.9% |
| Tongue Disorder |
5.9% |
| Visual Acuity Reduced |
5.9% |
| Abdominal Discomfort |
2.9% |
| Abdominal Pain |
2.9% |
| Adverse Event |
2.9% |
| Akathisia |
2.9% |
| Constipation |
2.9% |
| Dysarthria |
2.9% |
| Dysphagia |
2.9% |
| Dystonia |
2.9% |
| Extrapyramidal Disorder |
2.9% |
| Fall |
2.9% |
| Feeling Abnormal |
2.9% |
| Hallucination |
2.9% |
| Headache |
2.9% |
|
| Secondary |
| Product Used For Unknown Indication |
21.2% |
| Schizophrenia, Paranoid Type |
14.8% |
| Bipolar Disorder |
13.8% |
| Schizophrenia |
13.5% |
| Major Depression |
6.0% |
| Drug Use For Unknown Indication |
5.7% |
| Depression |
5.2% |
| Extrapyramidal Disorder |
3.3% |
| Psychotic Disorder |
2.4% |
| Anxiety |
1.9% |
| Bipolar I Disorder |
1.7% |
| Mental Disorder |
1.7% |
| Agitation |
1.4% |
| Ill-defined Disorder |
1.3% |
| Insomnia |
1.1% |
| Maternal Exposure During Pregnancy |
1.1% |
| Schizoaffective Disorder |
1.1% |
| Smoking Cessation Therapy |
1.1% |
| Drug Exposure During Pregnancy |
0.9% |
| Asthma |
0.8% |
|
| Weight Increased |
12.9% |
| Weight Decreased |
10.6% |
| Treatment Noncompliance |
7.1% |
| Tremor |
7.1% |
| Vision Blurred |
7.1% |
| Small For Dates Baby |
5.9% |
| Suicide Attempt |
5.9% |
| Insomnia |
4.7% |
| Swollen Tongue |
4.7% |
| Confusional State |
3.5% |
| Lipids Decreased |
3.5% |
| Placental Disorder |
3.5% |
| Renal Failure Acute |
3.5% |
| Strabismus |
3.5% |
| Tardive Dyskinesia |
3.5% |
| Tongue Disorder |
3.5% |
| Back Pain |
2.4% |
| Bipolar Disorder |
2.4% |
| Depression |
2.4% |
| Drug Hypersensitivity |
2.4% |
|
| Concomitant |
| Schizophrenia |
17.0% |
| Product Used For Unknown Indication |
14.8% |
| Bipolar Disorder |
8.4% |
| Depression |
8.1% |
| Anxiety |
7.7% |
| Psychotic Disorder |
5.2% |
| Schizoaffective Disorder |
4.5% |
| Drug Use For Unknown Indication |
4.2% |
| Lower Limb Fracture |
3.9% |
| Insomnia |
3.3% |
| Hypertension |
3.1% |
| Pain |
3.0% |
| Mental Disorder |
2.3% |
| Sleep Disorder |
2.2% |
| Schizophrenia, Paranoid Type |
2.2% |
| Irritability |
2.1% |
| Diabetes Mellitus |
2.0% |
| Extrapyramidal Disorder |
2.0% |
| Cellulitis |
2.0% |
| Agitation |
1.9% |
|
| Type 2 Diabetes Mellitus |
17.0% |
| Weight Increased |
16.4% |
| Granulocytopenia |
6.1% |
| Leukopenia |
5.5% |
| Withdrawal Syndrome |
5.5% |
| Vomiting |
5.2% |
| Tardive Dyskinesia |
4.6% |
| Schizophrenia |
4.5% |
| Weight Decreased |
4.2% |
| Psychotic Disorder |
3.6% |
| Tremor |
3.6% |
| Overdose |
3.4% |
| Death |
3.3% |
| Suicidal Ideation |
3.1% |
| Urinary Tract Infection |
2.9% |
| White Blood Cell Count Decreased |
2.7% |
| Depression |
2.4% |
| Treatment Noncompliance |
2.2% |
| Somnolence |
2.1% |
| Wound Infection |
2.0% |
|
| Interacting |
| Product Used For Unknown Indication |
61.1% |
| Drug Use For Unknown Indication |
16.7% |
| Schizoaffective Disorder |
8.3% |
| Schizophrenia |
8.3% |
| Analgesic Therapy |
1.4% |
| Anxiety |
1.4% |
| Diabetes Mellitus |
1.4% |
| Smoking Cessation Therapy |
1.4% |
|
| Verbigeration |
22.2% |
| Agranulocytosis |
11.1% |
| Hallucination |
11.1% |
| Irritability |
11.1% |
| Speech Disorder |
11.1% |
| Toxicity To Various Agents |
11.1% |
| Tremor |
11.1% |
| Unevaluable Event |
11.1% |
|
